Profit growth in tandem with revenue over the last 3 quarters. It's still traded at lowest PER 14x in pharmaceutical manufacturing sector. Both Biohldg & Hovid are traded at PER 20x.
Revenue grow by 7%, 13% and 15% for the immediate last 3 quarters. Growth is expected to continue for next few quarter. It will attract a lot of attention from investors who are looking for a growth company.
Does make sense. The number of aging parents keeps on increasing from year to year, and the number of population keeps on elevating as well. So, lots of medicine and vitamins are needed. Just look at AHealth. After giving bonus, its price has gone back to RM4 plus. YSPSAH is another AHealth in the making.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
pang72
51,625 posts
Posted by pang72 > 2015-05-15 18:07 | Report Abuse
Soon. I thought ysp making Viagra. So the stock climb up So high like the demand and the drug